Seres Therapeutics Inc
Research Seres Therapeutics Inc (MCRB) on Bullrun: market cap USD 74.72M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMCRB
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 74.72M
- Financial periodFY2025
- RevenueUSD 789.00K
- Net incomeUSD 5.70M
- Free cash flowUSD 865.00K
Valuation Snapshot
latest market cap is USD 74.72M.
About Seres Therapeutics Inc
Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational oral live biotherapeutic to decolonize GI pathogens, enhance GI epithelial barrier integrity, and regulate immune response to prevent bacterial bloodstream infections, as well as other pathogen-associated negative clinical outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation.
Frequently asked questions
What is Seres Therapeutics Inc's market cap?
Seres Therapeutics Inc's market capitalization is USD 74.72M.
What does Seres Therapeutics Inc do?
Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational oral live biotherapeutic to decolonize GI pathogens, enhance GI epithelial barrier integrity, and regulate immune response to prevent...